AA
REGN icon

Ancora Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Ancora Advisors’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$81.1K Hold
105
– – ﹤0.01% 971
2025
Q4 		$81K Buy
105
+45
+75% +$30.6K ﹤0.01% 986
2025
Q3 		$33.7K Hold
60
– – ﹤0.01% 1120
2025
Q2 		$31.5K Sell
60
-1
-2% -$558 ﹤0.01% 1123
2025
Q1 		$38.7K Sell
61
-9
-13% -$6.19K ﹤0.01% 1063
2024
Q4 		$49.9K Sell
70
-86
-55% -$72.2K ﹤0.01% 1003
2024
Q3 		$164K Buy
156
+1
+0.6% +$1.11K ﹤0.01% 731
2024
Q2 		$163K Hold
155
– – ﹤0.01% 708
2024
Q1 		$149K Hold
155
– – ﹤0.01% 736
2023
Q4 		$136K Sell
155
-37
-19% -$30.5K ﹤0.01% 747
2023
Q3 		$158K Sell
192
-13
-6% -$10.2K ﹤0.01% 706
2023
Q2 		$147K Buy
205
+8
+4% +$6.17K ﹤0.01% 716
2023
Q1 		$162K Buy
197
+40
+25% +$30.2K ﹤0.01% 692
2022
Q4 		$113K Buy
157
+2
+1% +$1.48K ﹤0.01% 806
2022
Q3 		$107K Hold
155
– – ﹤0.01% 886
2022
Q2 		$92K Sell
155
-2
-1% -$1.3K ﹤0.01% 996
2022
Q1 		$110K Sell
157
-17
-10% -$10.8K ﹤0.01% 993
2021
Q4 		$110K Buy
174
+17
+11% +$10.5K ﹤0.01% 994
2021
Q3 		$95K Sell
157
-12
-7% -$7.45K ﹤0.01% 997
2021
Q2 		$94K Sell
169
-95
-36% -$48.1K ﹤0.01% 935
2021
Q1 		$125K Hold
264
– – ﹤0.01% 816
2020
Q4 		$128K Hold
264
– – ﹤0.01% 700
2020
Q3 		$148K Buy
264
+14
+6% +$8.49K 0.01% 653
2020
Q2 		$156K Buy
250
+10
+4% +$5.68K 0.01% 629
2020
Q1 		$117K Buy
240
+50
+26% +$20.6K 0.01% 746
2019
Q4 		$71K Buy
+190
New +$63.9K ﹤0.01% 828

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Ancora Advisors's REGN Position: Q1 2026 in Review

Ancora Advisors held its Regeneron Pharmaceuticals (REGN) position steady in Q1 2026 at 105 shares worth $81.1K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

Ancora Advisors first reported a position in REGN in Q4 2019 and has held it in 26 quarters since. The position peaked at $164K in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Ancora Advisors held 105 shares of Regeneron Pharmaceuticals worth $81.1K as of Q1 2026.
  • Ancora Advisors left its Regeneron Pharmaceuticals share count unchanged in Q1 2026.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #971 holding.
  • Ancora Advisors first reported a position in Regeneron Pharmaceuticals in Q4 2019 and has held it in 26 quarters since.
  • Ancora Advisors's Regeneron Pharmaceuticals position peaked at $164K in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.